Antiphospholipid syndrome (APS) is an autoimmune disease and an acquired thrombophilia driven by a heterogeneous group of autoantibodies directed against phospholipids,1 phospholipid‐binding proteins and protein‐phospholipid complexes2 (antiphospholipid antibodies – aPL). This evidence concerns the gene FASLG and antiphospholipid syndrome.